[Serum kreatinkinase MB during fenoterol tocolysis (author's transl)].
In the investigation of possible myocardial damage, the assay of the heart specific isoenzyme kreatinkinase MB has established itself as a highly sensitive proof of a heart necrosis. In patients who underwent stationary treatment for premature contractions, the CK-activity was measured in the initial phase of tocolysis and additionally right before the therapy was ended. There was no laboratory indication of any heart damage due to tocolytic treatment.
D003402:Creatine Kinase / Q000378:metabolism*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006801:Humans; D007527:Isoenzymes; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011188:Potassium / Q000097:blood; D011247:Pregnancy
D004983:Ethanolamines; D007527:Isoenzymes; D005280:Fenoterol; D003402:Creatine Kinase; D011188:Potassium
Serumkreatinkinase BM während Fenoterol-Tokolyse.